TITLE

OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA83
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The prevalence of obesity is increasing worldwide. In the future, mortality related to obesity is expected to exceed that of smoking. Non-alcoholic fatty liver disease (NAFLD) is one the diseases that are induced by obesity. NAFLD has a spectrum of liver disease, ranging from simple steatosis to steatohepatitis (NASH), advanced fibrosis, an cirrhosis. The aim of this study was to determine the prevalence of NAFLD and its spectrum among obese patients. Prevalence of NASH among obese patients is about 6-10 times more than general population. Pathogenesis other than obesity is necessary to developing NASH.
ACCESSION #
13219139

 

Related Articles

  • Enfermedad hepática por depósito graso en pacientes no alcohólicos y no obesos: reflexiones a propósito de un caso. Aguado, I. Carabaño; Otones, L. Llorente; Vega, V. M. Suárez // Acta Pediátrica Española;mar2011, Vol. 69 Issue 3, p242 

    Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease in children and adolescents in some countries, as the United States of America. This fact may be due to a two-fold rise increase in rates of obesity in the last twenty years. The possible progress to...

  • The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Hartmann, Phillipp; Wei-Chung Chen; Schnabl, Bernd // Frontiers in Physiology;Sep2012, Vol. 3, preceding p1 

    Alcoholic liver disease (ALD) encompasses hepatic steatosis, which may progress to alcoholic hepatitis, fibrosis, and cirrhosis. It remains a leading cause of morbidity and mortality in the US and worldwide. The severity of liver disease correlates with plasma levels of bacterial products in...

  • The Increasing Mortality Attributed to Cirrhosis and Fatty Liver, in Baltimore (1957-1966). Kramer, Karl; Kuller, Lewis; Fisher, Russell // Annals of Internal Medicine;Aug68, Vol. 69 Issue 2, p273 

    Presents a study on cirrhosis and fatty liver mortality in Baltimore, Maryland between 1957 and 1966. Methodology used in the study; Analysis on the data gathered; Discussion on the results of the study. \

  • FATTY LIVER IN OBESE CHILDREN: A STUDY OF ULTRASONOGRAPHY AND LIVER ENZYME LEVELS IN HOSPITAL UNIVERSITI SAINS MALAYSIA. W. M., Wan Najwa Zaini; Lee Abdullah, Noreen Norfaraheen; Majid, Noorizan Abdul // Malaysian Journal of Medical Sciences;Jan2007 Supplement, Vol. 14, p86 

    Introduction: Childhood obesity is now a worldwide epidemic which is a great health challenge and difficult to control. Among the many aasociated health hazards is non-alcoholic fatty liver disease (NAFLD). It is a wide spectrum of liver disorders that progresses to liver failure or cirrhosis....

  • Nonalcoholic Fatty Liver Disease: An Underrecognized Cause of Cryptogenic Cirrhosis. Clark, Jeanne M.; Diehl, Anna Mae // JAMA: Journal of the American Medical Association;6/11/2003, Vol. 289 Issue 22, p3000 

    Cryptogenic cirrhosis is a common cause of liver-related morbidity and mortality in the United States. Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of cryptogenic cirrhosis. However, the diagnosis of cirrhosis in patients with NAFLD appears to be delayed...

  • Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD). Stepanova, Maria; Rafiq, Nila; Makhlouf, Hala; Agrawal, Ritambhara; Kaur, Ishmeet; Younoszai, Zahra; McCullough, Arthur; Goodman, Zachary; Younossi, Zobair // Digestive Diseases & Sciences;Oct2013, Vol. 58 Issue 10, p3017 

    Aim: Non-alcoholic steatohepatitis (NASH) patients are at increased risk for progression to cirrhosis. The aim of this study was to assess all-cause and liver-specific mortality in a cohort of non-alcoholic fatty liver disease (NAFLD) patients. Methods: Biopsy-proven NAFLD patients with and...

  • Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease. Chiba, Mayumi; Sasaki, Motoko; Kitamura, Seiko; Ikeda, Hiroko; Sato, Yasunori; Nakanuma, Yasuni // Journal of Clinical Pathology;Jun2011, Vol. 64 Issue 6, p564 

    Aims Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of pathological conditions, ranging from simple steatosis to hepatic fibrosis with progression to cirrhosis. While activated hepatic stellate cells (HSC) are known to be involved in intralobular, perisinuosidal fibrosis, the...

  • Liver fibrogenesis in non-alcoholic steatohepatitis. Zhaolian Bian; Xiong Ma // Frontiers in Physiology;Jul2012, Vol. 3, p1 

    Non-alcoholic fatty liver disease (NAFLD) is emerging as one of the most common chronic liver diseases in developed western countries. Non-alcoholic steatohepatitis (NASH) is the most severe form of NAFLD, and can progress to more severe forms of liver disease, including fibrosis, cirrhosis, and...

  • Obesity and diabetes epidemics spur increase in nonalcoholic steatohepatitis.  // Biomedical Market Newsletter;12/14/2011, Vol. 21, p1 

    The article focuses on a research according to which post-transplantation survival for nonalcoholic steatohepatitis (NASH) patients is excellent with one-year survival rates near 88 percent. NASH occurs when fat builds up in the liver which damages the liver and leads to cirrhosis. The research...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics